Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.48 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.48 |
| ▸ | FURIN | P09958 | 8/20 | 0.46 |
| ▸ | CPA1 | P15085 | 1/20 | 0.44 |
| ▸ | CPA2 | P48052 | 1/20 | 0.44 |
| ▸ | CPA4 | Q9UI42 | 1/20 | 0.44 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30598012 | 0.93 | SIRT6 (0.53) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL10609149 | 0.93 | SIRT6 (0.53) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL29564895 | 0.91 | SLC15A2 (0.49) | SIRT6SIRT1FURINSLC15A2 | |
| SCHEMBL29394605 | 0.91 | SIRT6 (0.56) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL29396101 | 0.89 | SIRT6 (0.55) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL29380200 | 0.89 | SLC15A2 (0.49) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL29565229 | 0.88 | SLC15A2 (0.51) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL14669744 | 0.87 | NMT2 (0.50) | SIRT6SIRT1FURINCPA1CPA2 | |
| SCHEMBL29398096 | 0.87 | GNPAT (0.53) | SIRT6SIRT1FURINCPA1CPA2 | |
| D-Alanine SCHEMBL5702807 | 0.87 | SIRT6 (0.52) | SIRT6SIRT1FURINCPA1CPA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0132117-A2 | A process for the preparation of purified vancomycin class antibiotics | SMITHKLINE BECKMAN CORPORATION (US) | 1985-01-23 | — | — | EP | disclosed |